VLST Corporation is dedicated to the streamlined discovery and development of novel therapeutics for the treatment of autoimmune and inflammatory disorders. VLST's proprietary platform is based on a thorough understanding of virulence factors and their function. This approach improves the prioritization of programs and reduces overall costs by improving the clinical success rate. We are Innovators. We are Partners. We are VLST.